annual EBITDA:
-$99.19M+$13.11M(+11.67%)Summary
- As of today (August 20, 2025), STOK annual EBITDA is -$99.19 million, with the most recent change of +$13.11 million (+11.67%) on December 31, 2024.
- During the last 3 years, STOK annual EBITDA has fallen by -$14.10 million (-16.58%).
- STOK annual EBITDA is now -1723.10% below its all-time high of -$5.44 million, reached on December 31, 2017.
Performance
STOK EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$26.24M-$138.56M(-123.36%)Summary
- As of today (August 20, 2025), STOK quarterly EBITDA is -$26.24 million, with the most recent change of -$138.56 million (-123.36%) on June 30, 2025.
- Over the past year, STOK quarterly EBITDA has increased by +$1.99 million (+7.05%).
- STOK quarterly EBITDA is now -123.36% below its all-time high of $112.32 million, reached on March 31, 2025.
Performance
STOK quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$44.64M+$1.99M(+4.67%)Summary
- As of today (August 20, 2025), STOK TTM EBITDA is $44.64 million, with the most recent change of +$1.99 million (+4.67%) on June 30, 2025.
- Over the past year, STOK TTM EBITDA has increased by +$154.53 million (+140.62%).
- STOK TTM EBITDA is now at all-time high.
Performance
STOK TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
STOK EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.7% | +7.0% | +140.6% |
| 3 y3 years | -16.6% | -7.5% | +147.2% |
| 5 y5 years | -181.6% | -109.4% | +199.8% |
STOK EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -16.6% | +11.7% | -123.4% | +18.2% | at high | +139.2% |
| 5 y | 5-year | -181.6% | +11.7% | -123.4% | +18.2% | at high | +139.2% |
| alltime | all time | -1723.1% | +11.7% | -123.4% | +18.2% | at high | +139.2% |
STOK EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$26.24M(-123.4%) | $44.64M(+4.7%) |
| Mar 2025 | - | $112.32M(-995.2%) | $42.65M(-144.0%) |
| Dec 2024 | -$99.19M(-11.7%) | -$12.55M(-56.6%) | -$96.93M(-14.0%) |
| Sep 2024 | - | -$28.89M(+2.3%) | -$112.75M(+2.6%) |
| Jun 2024 | - | -$28.23M(+3.6%) | -$109.90M(-3.4%) |
| Mar 2024 | - | -$27.26M(-3.9%) | -$113.76M(+3.4%) |
| Dec 2023 | -$112.30M(+9.2%) | -$28.37M(+9.0%) | -$110.04M(+2.2%) |
| Sep 2023 | - | -$26.03M(-18.9%) | -$107.69M(-0.2%) |
| Jun 2023 | - | -$32.09M(+36.3%) | -$107.89M(+7.7%) |
| Mar 2023 | - | -$23.54M(-9.5%) | -$100.19M(-0.6%) |
| Dec 2022 | -$102.81M(+20.8%) | -$26.02M(-0.8%) | -$100.82M(+2.1%) |
| Sep 2022 | - | -$26.22M(+7.5%) | -$98.70M(+4.4%) |
| Jun 2022 | - | -$24.40M(+1.0%) | -$94.59M(+3.2%) |
| Mar 2022 | - | -$24.17M(+1.1%) | -$91.69M(+9.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$85.09M(+63.1%) | -$23.91M(+8.1%) | -$83.83M(+13.3%) |
| Sep 2021 | - | -$22.11M(+2.8%) | -$74.01M(+13.7%) |
| Jun 2021 | - | -$21.50M(+31.8%) | -$65.12M(+16.0%) |
| Mar 2021 | - | -$16.32M(+15.9%) | -$56.15M(+9.3%) |
| Dec 2020 | -$52.16M(+48.1%) | -$14.08M(+6.6%) | -$51.37M(+6.5%) |
| Sep 2020 | - | -$13.21M(+5.5%) | -$48.22M(+7.8%) |
| Jun 2020 | - | -$12.53M(+8.6%) | -$44.72M(+10.3%) |
| Mar 2020 | - | -$11.54M(+5.6%) | -$40.53M(+15.0%) |
| Dec 2019 | -$35.23M(+180.3%) | -$10.93M(+12.5%) | -$35.23M(+45.0%) |
| Sep 2019 | - | -$9.72M(+16.5%) | -$24.30M(+66.6%) |
| Jun 2019 | - | -$8.34M(+33.6%) | -$14.58M(+133.6%) |
| Mar 2019 | - | -$6.24M(+232.0%) | -$6.24M(+232.0%) |
| Dec 2018 | -$12.57M(+131.0%) | - | - |
| Mar 2018 | - | -$1.88M | -$1.88M |
| Dec 2017 | -$5.44M | - | - |
FAQ
- What is Stoke Therapeutics, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Stoke Therapeutics, Inc.?
- What is Stoke Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Stoke Therapeutics, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Stoke Therapeutics, Inc.?
- What is Stoke Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Stoke Therapeutics, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Stoke Therapeutics, Inc.?
- What is Stoke Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Stoke Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of STOK is -$99.19M
What is the all time high annual EBITDA for Stoke Therapeutics, Inc.?
Stoke Therapeutics, Inc. all-time high annual EBITDA is -$5.44M
What is Stoke Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, STOK annual EBITDA has changed by +$13.11M (+11.67%)
What is Stoke Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of STOK is -$26.24M
What is the all time high quarterly EBITDA for Stoke Therapeutics, Inc.?
Stoke Therapeutics, Inc. all-time high quarterly EBITDA is $112.32M
What is Stoke Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, STOK quarterly EBITDA has changed by +$1.99M (+7.05%)
What is Stoke Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of STOK is $44.64M
What is the all time high TTM EBITDA for Stoke Therapeutics, Inc.?
Stoke Therapeutics, Inc. all-time high TTM EBITDA is $44.64M
What is Stoke Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, STOK TTM EBITDA has changed by +$154.53M (+140.62%)